ClinicalTrials.govpublic full text
A Study of Health-Related Quality of Life in People With Multiple Myeloma Receiving Daratumumab or Lenalidomide
multiple myeloma, daratumumab, lenalidomide, patient-reported health related, quality of life measures, 20-198, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 825384
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.